Tagrid Athlete Foot Antifungal with Tolnaftate

Manufacturer
TAGRID LLC
Effective date
2025-08-10
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
daily-update
Hydrated at
2026-09-29 01:03:09

Label at a glance#

ProductTagrid Athlete Foot Antifungal with Tolnaftate
Active ingredientTolnaftate
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient:

  1. Tolnaftate 1%

OTC - PURPOSE SECTION

  1. Antifungal

INDICATIONS & USAGE SECTION

Uses:

  1. Proven clinically effective in the treatment of most athlete’s foot (tinea pedis) and ringworm (tinea corporis).
  2. Helps prevent most athlete’s foot with daily use.
  3. For effective relief of itching, burning, and cracking.

WARNINGS SECTION

  • For external use only.
  • Avoid contact with eyes, mouth, or mucous membranes.
  • Do not apply to broken or irritated skin.
  • Flammable: Keep away from heat and flame.

OTC - DO NOT USE SECTION

Do not use:

  • On children under 2 years of age unless directed by a doctor.
  • For diaper rash.

OTC - WHEN USING SECTION

When using this product

  • Avoid contact with eyes.
  • Use only as directed.
  • If irritation occurs, stop use and consult a doctor.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • Condition worsens or does not improve within 2 weeks.
  • Excessive irritation or burning occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions:

  • Clean the affected area and dry thoroughly.
  • Spray a thin layer over affected area twice daily (morning and night).
  • For athlete’s foot: pay special attention to the spaces between the toes; wear well-fitting, breathable shoes, and change socks daily. Allow shoes to dry out between uses.

INACTIVE INGREDIENT SECTION

Inactive ingredients:

  • Water
  • Artemisia vulgaris extract
  • Kochia scoparia fruit extract
  • Dictamnus dasycarpus root extract
  • Smilax glabra root extract
  • Solidago decurrens fruiting top extract
  • Phellodendron amurense bark extract
  • Euphorbia fischeriana root extract
  • Gleditsia sinensis fruit extract
  • Stemona tuberosa root extract

OTHER SAFETY INFORMATION

  • Store between 20°C to 25°C (68°F to 77°F).
  • Avoid excessive heat and direct sunlight.
  • Protect from freezing.

OTC - QUESTIONS SECTION

Questions or comments?

Contact us at support@tagridstore.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Available in 100 mL, 50 mL and 30 mL can. All packages look the same externally, with the only variation being fill volume.

package boxpackage box

Can tagCan tag

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128X004S9HB8Jp1.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85384-001785384-0017-1, 85384-0017-2, 85384-0017-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32025-08-10weekly-update2026-07-17 21:43:19
22025-08-10full-release2026-06-01 01:36:02

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e5a2d440-8840-4502-924d-71294e369bbbd3c514e7-9913-4f8d-87ff-777563bec2372025-08-10WarningsExact identifier
spl set id: d3c514e7-9913-4f8d-87ff-777563bec237

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.